Low and intermediate risk
Showing 1 - 25 of >10,000
Low or Intermediate Risk Prostate Cancer Trial in Toronto (Advanced imaging for radiotherapy planning and guidance)
Active, not recruiting
- Low or Intermediate Risk Prostate Cancer
- Advanced imaging for radiotherapy planning and guidance
-
Toronto, Ontario, CanadaUniversity Health Network
Oct 21, 2022
Non-Hodgkin's Lymphoma Trial in New York (Etoposide, carboplatin, ifosfamide, Rituximab, Ifosfamide, Etoposide, Carboplatin,
Completed
- Non-Hodgkin's Lymphoma
- Etoposide, carboplatin, ifosfamide
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 23, 2022
Prostate Cancer Trial in Philadelphia (Proton Beam Radiation Therapy, Quality-of-Life assessment, Questionnaire Administration)
Terminated
- Prostate Cancer
- Proton Beam Radiation Therapy
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jan 30, 2023
Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])
Recruiting
- Pre-fibrotic Myelofibrosis
- Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
-
Taipei, Taiwan, 100, TaiwanNational Taiwan University Hospital
Feb 7, 2023
Breast Cancer Trial in Rozzano (external beams radiotherapy, brachytherapy)
Recruiting
- Breast Cancer
- external beams radiotherapy
- brachytherapy
-
Rozzano, Milano, ItalyIRCCS Istituto Clinico Humanitas
Jan 13, 2023
Anal Squamous Cell Carcinoma Trial (Radiotherapy - Low risk group, Radiotherapy - Standard risk group, Radiotherapy -
Not yet recruiting
- Anal Squamous Cell Carcinoma
- Radiotherapy - Low risk group
- +3 more
- (no location specified)
Sep 18, 2023
Prostate Cancer Trial in Chapel Hill (68Ga-HBED-CC-PSMA)
Recruiting
- Prostate Cancer
-
Chapel Hill, North CarolinaUniversity of North Carolina - Chapel Hill
Jan 31, 2023
Prostate Cancer Trial in Candiolo (Robotic hemi-prostatectomy with urethral preservation)
Recruiting
- Prostate Cancer
- Robotic hemi-prostatectomy with urethral preservation
-
Candiolo, TO, ItalyFondazione del Piemonte per l'Oncologia
Apr 16, 2023
Localized Prostate Cancer, Low Risk Prostate Cancer, Intermediate Risk Prostate Cancer Trial (3 fractions of prostate SBRT)
Not yet recruiting
- Localized Prostate Cancer
- +2 more
- 3 fractions of prostate SBRT
- (no location specified)
Oct 31, 2023
Prostate Cancer Trial in Roma (Soractelite Echolaser Transperineal focal laser ablation)
Recruiting
- Prostate Cancer
- Soractelite Echolaser Transperineal focal laser ablation
-
Roma, RM, ItalySan Carlo di Nancy Hospital
Oct 16, 2022
Rectal Cancer, Neoadjuvant Chemo Trial in Wuxi, Chengdu, Kunming (Capox chemo)
Recruiting
- Rectal Cancer
- Neoadjuvant Chemotherapy
- Capox chemotherapy
-
Wuxi, Jiangsu, China
- +3 more
Mar 16, 2022
Pulmonary Embolism Trial in Bispebjerg, Copenhagen, Herlev (Alteplase 20 Mg Powder for Solution for Injection Vial, Ultrasound
Recruiting
- Pulmonary Embolism
- Alteplase 20 Mg Powder for Solution for Injection Vial
- Ultrasound assisted Thrombolysis
-
Bispebjerg, Denmark
- +2 more
Oct 25, 2022
Bladder Cancer Trial in San Antonio (Intervention, Control)
Completed
- Bladder Cancer
- Intervention
- Control
-
San Antonio, TexasThe University of Texas Health Science Center
Jun 9, 2021
Prostate Cancer Trial in Nice (exclusive single-fraction irradiation)
Completed
- Prostate Cancer
- exclusive single-fraction irradiation
-
Nice, FranceCentre Antoine Lacassagne
Oct 5, 2021
MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral
Not yet recruiting
- Myelodysplastic Syndromes
- +3 more
- Subcutaneous azacitidine
- Oral decitabine/cedazuridine
-
Newcastle, New South Wales, AustraliaCalvary Mater Newcastle
May 29, 2023
Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)
Recruiting
- Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
-
Ocala, Florida
- +3 more
Jan 30, 2023
Prostate Cancer Trial (SUPR-SABR treatment)
Not yet recruiting
- Prostate Cancer
- SUPR-SABR treatment
- (no location specified)
Dec 20, 2022
Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary
Recruiting
- Pulmonary Embolism
- Tissue Plasminogen Activator, Alteplase
- Low-molecular weight heparin
-
İzmir, Bornova/İzmir, TurkeyEge University
Aug 22, 2022
Safety and Efficacy of Two-step Radical Prostatectomy
Recruiting
- Prostate Cancer
- Two-step Radical Prostatectomy
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Feb 1, 2023
Prostate Cancer Trial in Greenfield Park (HDR brachytherapy as monotherapy)
Completed
- Prostate Cancer
- HDR brachytherapy as monotherapy
-
Greenfield Park, Quebec, CanadaHôpital Charles LeMoyne
Mar 15, 2022
MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
- Oral Azacitidine
- Placebo for Oral Azacitidine
-
Buenos Aires, Argentina
- +1 more
Aug 1, 2022
Prostate Cancer Trial in Kelowna (Low dose rate prostate brachytherapy, High Dose Rate prostate brachytherapy)
Recruiting
- Prostate Cancer
- Low dose rate prostate brachytherapy
- High Dose Rate prostate brachytherapy
-
Kelowna, British Columbia, CanadaBritish Columbia Cancer Agency Center for the Southern Interior
Mar 3, 2022